Health disparities among cancer patients who received molecular testing for biomarker-directed therapy.
Heath E, Dyson G, Ribeiro JR, Xiu J, Poorman K, Mamdani H, Al Hallak MN, Shields AF, Elayoubi JA, Winer IS, Cackowski FC, Puckrein GA, Lopes GL, Jones N, Hauke RJ, Kareff SA, Radovich M, Sledge GW, Spetzler DB, Vidal GA, Marshall JL.
Heath E, et al. Among authors: lopes gl.
Cancer Res Commun. 2024 Aug 22. doi: 10.1158/2767-9764.CRC-24-0321. Online ahead of print.
Cancer Res Commun. 2024.
PMID: 39172022
Free article.